Leticia Rocha-Zavaleta

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsNatural products and bioactive compoundsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 20, 2026
The LNK adaptor protein: a dual regulator of proliferation and migration in solid tumors.

Jessica C Mantilla-Ollarves, Laura Velazquez, Leticia Rocha-Zavaleta

|Mar 23, 2024
Synthesis of Cycloartan-16β-ol from 16β 24R-Epoxy-Cycloartane and Their Cytotoxicity Evaluation Against Human Cancer Cell Lines.

Atzin Hernández-Flandes, Simón Hernández-Ortega, Teresa Ramírez-Apan

|Oct 14, 2023
Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer.

José A López-Mejía, Jessica C Mantilla-Ollarves, Leticia Rocha-Zavaleta

|Apr 13, 2023
Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.

Víctor Adrián Cortés-Morales, Luis Chávez-Sánchez, Leticia Rocha-Zavaleta

|Nov 26, 2022
Alteration of the IFN-Pathway by Human Papillomavirus Proteins: Antiviral Immune Response Evasion Mechanism.

Leonardo Josué Castro-Muñoz, Leticia Rocha-Zavaleta, Marcela Lizano

|Oct 31, 2019
IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis.

María Del Carmen Lagunas-Cruz, Arturo Valle-Mendiola, Jonathan Trejo-Huerta

Pageof 1

Frequent Collaborators

1 joint publications

Arturo Valle-Mendiola

1 joint publications

Isabel Soto-Cruz

1 joint publications

Marcela Lizano

1 joint publications

Joaquín Manzo-Merino